Publications by authors named "David Luckenbaugh"

Claim this Profile
F
Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.
Mark J Niciu, Bridget J Shovestul, Brittany A Jaso, Cristan Farmer, David A Luckenbaugh

J Affect Disord· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
Mark J Niciu, Nicolas D Iadarola, Dipavo Banerjee, David A Luckenbaugh, Minkyung Park

J Psychopharmacol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion.
Steven J Pennybaker, David A Luckenbaugh, Lawrence T Park, Craig A Marquardt, Carlos A Zarate

Biol Psychiatry· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case series: Antidepressant effects of low-affinity and low-trapping NMDA receptor antagonists did not predict response to ketamine in seven subjects.
Lauren Lepow, David A Luckenbaugh, Lawrence Park, Ioline D Henter, Carlos A Zarate

J Psychiatr Res· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Activity or Energy as a Primary Criterion for the Diagnosis of Bipolar Mania in DSM-5: Findings From the STEP-BD Study.
Rodrigo Machado-Vieira, David A Luckenbaugh, Elizabeth D Ballard, Ioline D Henter, Mauricio Tohen

Am J Psychiatry· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Change in cytokine levels is not associated with rapid antidepressant response to ketamine in treatment-resistant depression.
Minkyung Park, Laura E Newman, Philip W Gold, David A Luckenbaugh, Peixiong Yuan

J Psychiatr Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.
Steven J Pennybaker, Mark J Niciu, David A Luckenbaugh, Carlos A Zarate

J Affect Disord· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognition of emotional facial expressions in anxious and nonanxious depression.
Hannah E Berg, Elizabeth D Ballard, David A Luckenbaugh, Allison C Nugent, Dawn F Ionescu

Compr Psychiatry· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.
Allison C Nugent, Nicolas D Iadarola, Frank G Miller, David A Luckenbaugh, Carlos A Zarate

Lancet Psychiatry· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An assessment of the anti-fatigue effects of ketamine from a double-blind, placebo-controlled, crossover study in bipolar disorder.
Leorey N Saligan, David A Luckenbaugh, Elizabeth E Slonena, Rodrigo Machado-Vieira, Carlos A Zarate

J Affect Disord· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression.
Annie J Xu, Mark J Niciu, Nancy B Lundin, David A Luckenbaugh, Dawn F Ionescu

Neural Plast· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.
Erica M Richards, Daniel C Mathews, David A Luckenbaugh, Dawn F Ionescu, Rodrigo Machado-Vieira

Psychopharmacology (Berl)· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reliability of 7T (1) H-MRS measured human prefrontal cortex glutamate, glutamine, and glutathione signals using an adapted echo time optimized PRESS sequence: A between- and within-sessions investigation.
Níall Lally, Li An, Dipavo Banerjee, Mark J Niciu, David A Luckenbaugh

J Magn Reson Imaging· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a clinician-administered National Institutes of Health-Brief Fatigue Inventory: A measure of fatigue in the context of depressive disorders.
Leorey N Saligan, David A Luckenbaugh, Elizabeth E Slonena, Rodrigo Machado-Vieira, Carlos A Zarate

J Psychiatr Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline working memory activation deficits in dimensional anxious depression as detected by magnetoencephalography.
Dawn F Ionescu, Allison C Nugent, David A Luckenbaugh, Mark J Niciu, Erica M Richards

Acta Neuropsychiatr· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine.
Níall Lally, Allison C Nugent, David A Luckenbaugh, Mark J Niciu, Jonathan P Roiser

J Psychopharmacol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales.
David A Luckenbaugh, Rezvan Ameli, Nancy E Brutsche, Carlos A Zarate

J Psychiatr Res· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis